Detalus Advisors, LLC Merck & Co., Inc. Transaction History

Detalus Advisors, LLC

$320 Million
Q2 2025

A detailed history of Detalus Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Detalus Advisors, LLC holds 2,657 shares of MRK stock, worth $222,975. This represents 0.07% of its overall portfolio holdings.

Number of Shares

2,657

Previous 2,694 1.37%

Holding current value

$222,975

Previous $241,000 12.86%

% of portfolio

0.07%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 23, 2025	SELL	$73.47 - $87.12 $2,718 - $3,223	-37 Reduced 1.37%	2,657 $210,000
Q1 2025 Apr 28, 2025	SELL	$83.01 - $101.02 $1,660 - $2,020	-20 Reduced 0.74%	2,694 $241,000
Q4 2024 Feb 06, 2025	SELL	$96.31 - $114.76 $3,659 - $4,360	-38 Reduced 1.38%	2,714 $269,000
Q3 2024 Oct 22, 2024	SELL	$111.15 - $128.97 $2,223 - $2,579	-20 Reduced 0.72%	2,752 $312,000
Q2 2024 Jul 26, 2024	BUY	$123.8 - $132.96 $123 - $132	1 Added 0.04%	2,772 $343,000
Q1 2024 Apr 24, 2024	BUY	$113.24 - $131.95 $226 - $263	2 Added 0.07%	2,771 $365,000
Q4 2023 Jan 24, 2024	BUY	$100.18 - $109.02 $100 - $109	1 Added 0.04%	2,769 $301,000
Q3 2023 Oct 26, 2023	SELL	$102.95 - $114.33 $20,384 - $22,637	-198 Reduced 6.68%	2,768 $284,000
Q2 2023 Jul 28, 2023	BUY	$108.61 - $118.38 $21,830 - $23,794	201 Added 7.27%	2,966 $342,000
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $205 - $229	2 Added 0.07%	2,765 $294,000
Q4 2022 Feb 09, 2023	SELL	$87.44 - $112.11 $3,934 - $5,044	-45 Reduced 1.6%	2,763 $306,000
Q3 2022 Nov 04, 2022	SELL	$84.53 - $94.96 $19,272 - $21,650	-228 Reduced 7.51%	2,808 $242,000
Q2 2022 Jul 27, 2022	SELL	$83.49 - $94.64 $344,980 - $391,052	-4,132 Reduced 57.65%	3,036 $277,000
Q1 2022 Apr 25, 2022	SELL	$73.51 - $82.4 $11,394 - $12,772	-155 Reduced 2.12%	7,168 $588,000
Q4 2021 Jan 18, 2022	SELL	$72.28 - $90.54 $7,083 - $8,872	-98 Reduced 1.32%	7,323 $561,000
Q3 2021 Oct 20, 2021	BUY	$71.68 - $78.83 $4,444 - $4,887	62 Added 0.84%	7,421 $557,000
Q2 2021 Jul 14, 2021	BUY	$70.31 - $77.77 $517,411 - $572,309	7,359 New	7,359 $572,000
Q3 2020 Nov 18, 2020	SELL	$73.18 - $82.95 $232,566 - $263,615	-3,178 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $140 - $160	2 Added 0.06%	3,178 $246,000
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $126 - $175	2 Added 0.06%	3,176 $244,000
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $246,238 - $277,851	3,174 New	3,174 $289,000

Others Institutions Holding MRK

# of Institutions

3,849

Shares Held

1.96B

Call Options Held

29.2M

Put Options Held

30M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $213B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Detalus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Detalus Advisors, LLC with notifications on news.

Account

Detalus Advisors, LLC Merck & Co., Inc. Transaction History